Nautilus Biotechnology, Inc. Lessee, Operating Lease, Liability, Undiscounted Excess Amount
Nautilus Biotechnology, Inc. (NAUT) had Lessee, Operating Lease, Liability, Undiscounted Excess Amount of $6.97 million as of 2026-06-30, per its 10-Q filed 2026-07-28.
Financial Statements › Notes › Leases
us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount · last filed 2026-07-28
- 2026-06-30: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $6.97M.
- 2026-03-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $7.58M.
- 2025-12-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $8.21M.
- 2025-09-30: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $7.00M.
| Period end | Lessee, Operating Lease, Liability, Undiscounted Excess Amount |
|---|---|
| 2026-06-30 | $6.97M 10-Q · filed 2026-07-28 |
| 2026-03-31 | $7.58M 10-Q · filed 2026-04-28 |
| 2025-12-31 | $8.21M 10-K · filed 2026-02-26 |
| 2025-09-30 | $7.00M 10-Q · filed 2025-10-28 |
| 2025-06-30 | $7.62M 10-Q · filed 2025-07-31 |
| 2025-03-31 | $8.25M 10-Q · filed 2025-04-29 |
| 2024-12-31 | $8.90M 10-K · filed 2025-02-27 |
| 2024-09-30 | $9.59M 10-Q · filed 2024-10-29 |
| 2024-06-30 | $10.30M 10-Q · filed 2024-07-30 |
| 2024-03-31 | $11.02M 10-Q · filed 2024-04-30 |
| 2023-12-31 | $11.77M 10-K · filed 2024-02-28 |
| 2023-09-30 | $12.55M 10-Q · filed 2023-10-31 |
| 2023-06-30 | $13.34M 10-Q · filed 2023-08-02 |
| 2023-03-31 | $14.13M 10-Q · filed 2023-05-02 |
| 2022-12-31 | $12.67M 10-K · filed 2023-02-23 |
| 2022-09-30 | $13.06M 10-Q · filed 2022-11-01 |
| 2022-06-30 | $13.69M 10-Q · filed 2022-08-02 |
| 2022-03-31 | $14.32M 10-Q · filed 2022-05-03 |
| 2021-12-31 | $14.96M 10-K · filed 2022-02-24 |
| 2021-09-30 | $756.00K 10-Q · filed 2021-11-02 |
| 2021-06-30 | $18.00K 10-Q · filed 2021-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |